NHS National Framework for the supply of Generics Housekeeping / Supply Chain Resilience Products, commencing 1 June 2025
A Contract Award Notice
by NHS ENGLAND
- Source
- Find a Tender
- Type
- Framework (Goods)
- Duration
- not specified
- Value
- £1
- Sector
- HEALTH
- Published
- 08 May 2025
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
United Kingdom: Please refer to Document 3, Schedule 8 in the ITO Documents for the list of purchasing points
1 buyer
- NHS England London
31 suppliers
- Accord Devon
- Kent Pharma Kent
- Wockhardt Wrexham
- Luye Pharma Surrey
- Milpharm Middlesex
- Ennogen Healthcare Kent
- Amarox Middlesex
- Novumgen London
- Teva Castleford
- Rosemont Pharmaceuticals Leeds
- Macleods Pharma Billingham
- Medreich Feltham
- Drugsrus Northwood
- Panpharma Southport
- Fresenius Kabi Cheshire
- Bowmed Ibisqus Manchester
- Aspire Pharma Surrey
- Morningside Pharmaeuticals Northampton
- Mylan Hatfield
- Pfizer Kent
- Mercury Pharmaceuticals London
- Neon Healthcare Hertford
- Martindale Pharma Essex
- Farmak Pharmaceuticals Hull
- B Braun Medical Sheffield
- Drreddys Laboratories Cambridge
- Hameln Pharma Gloucestershire
- JCSH Pharma Surrey
- Seacross Pharmaceuticals London
- Grindeks Kalceks Norwich
- SVP Pharma Norwich
Description
Project title: NHS National Framework for the supply of Generics Housekeeping / Supply Chain Resilience Products, commencing 1 June 2025Offer reference number: CM/PHG/24/5720Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement:CM/PHG/24/5720/01 – Orals (plus non-parenteral) ProductsCESW: (Midlands and Southwest): 1st June 2025 to 31st May 2027 (24 months)NWLN: (Northwest and London North): 1st June 2025 to 31st May 2027 (24 months)LSNE: (London South and Northeast): 1st June 2025 to 31st May 2027 (24 months)CM/PHG/24/5720/02 – Hospital Only ProductsDCE (Midlands) & DSW (Southwest): 1st June 2025 to 31st May 2026 (12 months)DNW (Northwest) & DLN (London North): 1st June 2025 to 31st January 2027 (20 months)DLS (London South) & DNE (Northeast): 1st June 2025 to 31st May 2026 (12 months)Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England
Lot Division
| 1 | CM/PHG/24/5720/01 – Orals (plus non-parenteral) Products CM/PHG/24/5720/01 – Orals (plus non-parenteral) ProductsCESW: (Midlands and Southwest): 01/06/2025 to 31/05/2027 (24 months) NWLN: (Northwest and London North): 01/06/2025 to 31/05/2027 (24 months)LSNE: (London South and Northeast): 01/06/2025 to 31/05/2027 (24 months) Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents. |
| 2 | CM/PHG/24/5720/02 – Hospital Only Products CM/PHG/24/5720/02 – Hospital Only ProductsDCE (Midlands) & DSW (Southwest): 01/06/2025 to 31/05/2026 (12 months), DNW (Northwest) & DLN (London North): 01/06/2025 to 31/01/2027 (20 months) DLS (London South) & DNE (Northeast): 01/06/2025 to 31/05/2026 (12 months) |
Award Detail
| 1 | Accord (Devon)
|
| 2 | Kent Pharma (Kent)
|
| 3 | Wockhardt (Wrexham)
|
| 4 | Luye Pharma (Surrey)
|
| 5 | Milpharm (Middlesex)
|
| 6 | Ennogen Healthcare (Kent)
|
| 7 | Amarox (Middlesex)
|
| 8 | Novumgen (London)
|
| 9 | Teva (Castleford)
|
| 10 | Rosemont Pharmaceuticals (Leeds)
|
| 11 | Macleods Pharma (Billingham)
|
| 12 | Medreich (Feltham)
|
| 13 | Drugsrus (Northwood)
|
| 14 | Panpharma (Southport)
|
| 15 | Accord (Devon)
|
| 16 | Fresenius Kabi (Cheshire)
|
| 17 | Kent Pharma (Kent)
|
| 18 | Wockhardt (Wrexham)
|
| 19 | Bowmed Ibisqus (Manchester)
|
| 20 | Aspire Pharma (Surrey)
|
| 21 | Morningside Pharmaeuticals (Northampton)
|
| 22 | Milpharm (Middlesex)
|
| 23 | Mylan (Hatfield)
|
| 24 | Pfizer (Kent)
|
| 25 | Mercury Pharmaceuticals (London)
|
| 26 | Teva (Castleford)
|
| 27 | Neon Healthcare (Hertford)
|
| 28 | Martindale Pharma (Essex)
|
| 29 | Farmak Pharmaceuticals (Hull)
|
| 30 | B Braun Medical (Sheffield)
|
| 31 | Drreddys Laboratories (Cambridge)
|
| 32 | Hameln Pharma (Gloucestershire)
|
| 33 | JCSH Pharma (Surrey)
|
| 34 | Seacross Pharmaceuticals (London)
|
| 35 | Grindeks Kalceks (Norwich)
|
| 36 | SVP Pharma (Norwich)
|
Renewal Options
Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months
Award Criteria
| price | _ |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Options are available.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. **
Reference
- ocds-h6vhtk-04d048
- FTS 019881-2025